Literature DB >> 9313671

Spermatic-cord block improves analgesia for day-case testicular surgery.

R J Burden1, S W O'Kelly, D Sutton, J Cumming.   

Abstract

OBJECTIVE: To assess whether the use of a spermatic-cord block contributes any additional analgesia to that of a conventional analgesic regimen in day-case testicular surgery. PATIENTS AND METHODS: In a randomized, double-blind controlled study, 48 patients undergoing day-case testicular surgery received general anaesthesia together with fentanyl and diclofenac for analgesia. In addition, 22 of these patients received 10 mL of 0.5% plain bupivacaine into the spermatic cord at the conclusion of surgery. Visual-analogue pain scores were recorded for each group over the following 24 h.
RESULTS: The visual-analogue pain scores were significantly lower in the immediate recovery period in patients receiving the spermatic-cord block.
CONCLUSION: The spermatic-cord block reduced discomfort in the immediate post-operative period in patients undergoing testicular surgery and the procedure should be encouraged to improve the quality of post-operative pain management in such procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313671     DOI: 10.1046/j.1464-410x.1997.00305.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Elective orchidopexy in the paediatric population: a trial of intra-operative spermatic cord block.

Authors:  A H Blatt; J G Cassey
Journal:  Pediatr Surg Int       Date:  2006-10-20       Impact factor: 1.827

2.  [Spermatic cord block and periscrotal block according to Reclus. Alternative procedure for critically ill patients].

Authors:  S T Lorenz; K Renkawitz
Journal:  Anaesthesist       Date:  2008-09       Impact factor: 1.041

3.  Efficacy of local dexmedetomidine add-on for spermatic cord block anesthesia in patients undergoing intrascrotal surgeries: randomized controlled multicenter clinical trial.

Authors:  Diab Fuad Hetta; Emad E Kamal; Ali M Mahran; Doaa G Ahmed; Abdelraheem Elawamy; Abdelraouf Ms Abdelraouf
Journal:  J Pain Res       Date:  2017-11-08       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.